CVMD Chemistry, PharmaTherapeutics Research and Development, Pfizer, Inc., 558 Eastern Point Road, Groton, Connecticut 06340.
J Chem Inf Model. 2010 Apr 26;50(4):547-59. doi: 10.1021/ci900497d.
The MM-GB/SA scoring technique has become an important computational approach in drug design. We, and others, have demonstrated that for congeneric molecules the correlation with experimental data obtained with the physics-based scoring is usually superior to scoring functions from typical docking algorithms. Despite showing good accuracy when applied within a series, much work is necessary to improve the MM-GB/SA method in order to gain greater efficiency in drug design. Here, we investigate the poor estimation of protein desolvation provided by the GB/SA solvation model and the large dynamic range observed in the MM-GB/SA scoring compared to that of the experimental data. In the former, replacing the GB/SA protein desolvation in the MM-GB/SA method by the free energy associated with displacing binding site waters upon ligand binding estimated by WaterMap provides the best results when ranking congeneric series of factor Xa and cyclin-dependent kinase 2 (CDK2) inhibitors. However, the improvement is modest over results obtained with the MM-GB/SA and WaterMap methods individually, apparently due to the high correlation between the free energy liberation of the displaced solvent and the protein-ligand van der Waals interactions, which in turn may be interpretable as estimates of the hydrophobic effect and hydrophobic-like interactions, respectively. As for the large dynamic range, comparisons between MM-GB/SA and FEP calculations indicate that for the factor Xa test set this problem has its origin in the lack of shielding effects of protein--ligand electrostatic interactions; that overly favors ligands that engage in hydrogen bonds with the protein.
MM-GB/SA 评分技术已成为药物设计中一种重要的计算方法。我们和其他人已经证明,对于同系列分子,与基于物理的评分方法获得的实验数据的相关性通常优于典型对接算法的评分函数。尽管在一系列应用中表现出良好的准确性,但仍需要大量工作来改进 MM-GB/SA 方法,以在药物设计中获得更高的效率。在这里,我们研究了 GB/SA 溶剂化模型提供的蛋白质去溶剂化的估计不佳,以及 MM-GB/SA 评分与实验数据相比观察到的大动态范围。在前一种情况下,通过 WaterMap 估计配体结合时取代结合位点水的自由能来取代 MM-GB/SA 方法中的 GB/SA 蛋白质去溶剂化,在对 factor Xa 和细胞周期蛋白依赖性激酶 2 (CDK2) 抑制剂的同系列进行排序时,提供了最佳结果。然而,与 MM-GB/SA 和 WaterMap 方法单独获得的结果相比,这种改进是适度的,显然是由于被取代溶剂的自由能释放与蛋白质-配体范德华相互作用之间的高度相关性,而这反过来又可以分别解释为疏水性效应和疏水性相互作用的估计。至于大的动态范围,MM-GB/SA 和 FEP 计算之间的比较表明,对于 factor Xa 测试集,这个问题的根源在于缺乏蛋白质-配体静电相互作用的屏蔽效应;这过分有利于与蛋白质形成氢键的配体。